Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17247-58-4

Post Buying Request

17247-58-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17247-58-4 Usage

Chemical Properties

clear colorless liquid

Uses

(Bromomethyl)cyclobutane may be used in the synthesis of racemic 3-cyclobutylalanine and 17-(cyclobutylmethyl)morphinan-3-ol (butorphan).

Preparation

The preparation of (Bromomethyl)cyclobutane is as follows:Into a clean, dry reactor equipped with a stirrer and under nitrogen are successively loaded 5.4 kg of DMF (5.1 eqV) and then 4.53 kg of triphenylphosphite. 2.34 kg of bromine is then introduced while maintaining the temperature at less than 12°C. The stirring speed is regulated according to the fluidity of the reaction medium.10065] The set point of the jacket is then adjusted to -12°C. and then 1.120 kg of cyclobutylmethanol is introduced in such a way as not to exceed a temperature of -5° C. At the end of the addition the whole is allowed to return slowly to room temperature. After distillation and washing, the final product 2b (mass 1.529 kg) having a GC relative purity of 98.3% is obtained with a yield of 78%.

General Description

(Bromomethyl)cyclobutane (bromomethyl-cyclobutane) is an aryl fluorinated building block. Its reaction with various hydroxychromen-4-one derivatives in the presence of anhydrous K2CO3/dry acetone and Bu4N+I- (PTC) has been investigated.

Check Digit Verification of cas no

The CAS Registry Mumber 17247-58-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,4 and 7 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17247-58:
(7*1)+(6*7)+(5*2)+(4*4)+(3*7)+(2*5)+(1*8)=114
114 % 10 = 4
So 17247-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H9Br/c6-4-5-2-1-3-5/h5H,1-4H2

17247-58-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (441171)  (Bromomethyl)cyclobutane  97%

  • 17247-58-4

  • 441171-5ML

  • 1,396.98CNY

  • Detail
  • Aldrich

  • (441171)  (Bromomethyl)cyclobutane  97%

  • 17247-58-4

  • 441171-25ML

  • 4,843.80CNY

  • Detail

17247-58-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (Bromomethyl)cyclobutane

1.2 Other means of identification

Product number -
Other names (Bromomethyl)Cyclobutane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17247-58-4 SDS

17247-58-4Relevant articles and documents

SYNTHESIS AND STRUCTURE OF , A PLATINUM(II) COMPLEX CONTAINING THE NEW LIGAND (DI-t-BUTYL)CYCLOBUTYLMETHYLPHOSPHINE

Simms, Barbara L.,Ibers, James A.

, p. 137 - 146 (1987)

The synthesis and spectral properties of trans-dichlorobis((di-t-butyl)cyclobutylmethylphosphine)platinum(II), , and of the new phosphine (di-t-butyl)cyclobutylmethylphosphine, , are described.The crystal structure of the Pt complex has been determined.The material crystallizes in the monoclinic system, space group C52h-P21/c, with two formula units in a cell of dimensions a 8.521(2), b 12.774(1), c 14.374(2) Angstroem, β 104.71(2) deg.A total of 5667 unique reflections were measured on a CAD4 diffractometer at 113 K.The final value of R(F) is 0.028 for those 4223 reflections having Fo2 > 3?(F2).The crystal structure consists of the packing of discrete neutral molecules of .A crystallographic center of symmetry is imposed on each molecule.Important intramolecular distances include Pt-P, 2.353(1) and Pt-Cl, 2.306(1) Angstroem.The shortest non-bonding distance between the Cl atom and a carbon atom of a t-Bu group is Cl...C(4), 3.387(3) Angstroem.No interaction between the Pt atom and the cyclobutane ring is observed.The absence of extreme steric congestion in the complex may explain the lack of such an interaction.

Rearrangement of the Grignard reagent from 1-methylcyclobutylmethyl bromide: origins of the methyl substituent effect

Hill, E. Alexander,Hallade, Marc W.

, p. 263 - 272 (1988)

1-Methyl substitution leads to a small decrease (ca. 0.45) in the rate of the ring cleavage rearrangement of cyclobutylmethylmagnesium bromide.Comparison with literature data for 3- and 5-membered rings indicates that the methyl substituent shifts the equilibrium in the direction of ring cleavage, mostly by stabilization of the double bond of the open isomer, and possibly partly by destabilization of the organometallic function of the cyclic isomer.The reaction rate is decreased in both directions, probably because of increased transition state steric repulsions.

Synthesis method of analgesic intermediate bromomethyl cyclobutane

-

Paragraph 0009; 0010; 0011; 0012; 0013; 0014, (2017/07/21)

The invention relates to a synthesis method of analgesic intermediate bromomethyl cyclobutane. The synthesis method comprises the following steps: by taking ethylene and acrylic acid as starting materials, carrying out Diels-Alder reaction to obtain cyclobutanecarboxylic acid, then reducing to obtain cyclobutanemethanol, and then brominating to obtain high-purity bromomethyl cyclobutane, wherein the total yield reaches more than 65%. The synthesis method provided by the invention has the advantages of available raw materials, mild reaction conditions, simple postprocessing operation, small environmental pollution, short reaction time, high reaction operational safety, high reaction yield, good product quality and low cost, and industrial production is facilitated.

2-PHENYLPYRIDINE DERIVATIVE

-

, (2008/06/13)

The present invention relates to a novel 2-phenylpyridine derivative or a salt thereof, wherein the pyridine ring is substituted with a carboxyl group or the like and the benzene ring has an electron-withdrawing group such as a cyano group and an electron-donating group such as a substituted alkoxy group at the same time. Since the compound of the invention has good xanthine oxidase-inhibitory action and uric acid-lowering action and does not have a structure derived from nucleic acid, the compound has advantages of high safety and excellent effects as compared with conventional compounds and is useful as a therapeutic or preventive agent for hyperuricemia, gout, inflammatory bowel diseases, diabetic kidney diseases, diabetic retinopathy, or the like.

Triazole derivatives

-

, (2011/03/17)

The present invention relates to triazole and imidazole derivatives of formula I and to their pharmaceutically acceptable acid addition salts. These compounds are NMDA receptor subtype blockers and are useful for the treatment of diseases related to the NMDA receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17247-58-4